Don’t miss what’s (ImmunoID) NeXT: A Comprehensive Platform for Immuno-Oncology – Improving Neoantigen Prediction, Evaluating Tumor Dynamics & Immunogenomics Profiling

Time: 9:30 am
day: Day One


• Accurate assessment of mutational landscape and putative neoantigens from the analytically-validated exome and transcriptome ImmunoID NeXT platform
• Improved neoantigen presentation and binding predictions through a machine learning algorithm, SHERPA, built upon high quality immunopeptidomics training data from mono-allelic, and multi-allelic samples
• Comprehensive immunogenomics profiling from a single sample to guide neoantigen-based therapies today and enable future biomarker discovery